ACTIVE

INNOVATIVE PHARMACEUTICS

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
77,4 k €
-21.5% YoY
Gross margin
21,2 k €
-68.7% YoY
Equity
2,2 M €
+3.6% YoY

What does INNOVATIVE PHARMACEUTICS do?

INNOVATIVE PHARMACEUTICS is a Private limited company incorporated in 2006. Its main activity is: Agents involved in the sale of food, beverages and tobacco. Its registered office is in Gent.

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0883.574.582
Incorporation
18/09/2006
Legal form
Private limited company
Registered office
Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map
Contributed capital
30 000,00 €
Latest accounts
31/12/2025
Activities (NACE)
46170Agents involved in the sale of food, beverages and tobacco· main46170Agents involved in the sale of food, beverages and tobacco51170Passenger air transport
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 19 financial years

2025202420232022202120202019201820172016201520142013201220112010200920082007
Income statement
Gross margin21,2 k €67,7 k €75,2 k €24 k €127,7 k €2,2 M €23,3 k €15 k €69,3 k €54,4 k €57,4 k €53,6 k €77,1 k €180,5 k €49,2 k €26,8 k €5,9 k €-25,2 k €-62,5 k €
EBITDA18,8 k €65,9 k €66,3 k €21,6 k €127,4 k €2,2 M €24,7 k €22,2 k €62,1 k €52,4 k €61,6 k €48,5 k €76,3 k €167,3 k €48,6 k €26,2 k €5,3 k €-26,1 k €-63,4 k €
Operating result21 k €63,6 k €66,3 k €28,4 k €128,3 k €2,2 M €24,7 k €22,2 k €62,1 k €52,4 k €57,3 k €44,2 k €72,1 k €162,1 k €48,6 k €26,2 k €2,6 k €32,7 k €-128,2 k €
Net result77,4 k €98,6 k €36,5 k €17,4 k €100,7 k €1,5 M €20,8 k €15 k €47,7 k €27,9 k €49,4 k €38,2 k €44,5 k €111 k €36,9 k €22,3 k €2,2 k €33,1 k €-82,2 k €
Balance sheet
Equity2,2 M €2,1 M €2 M €2 M €2 M €1,9 M €396,8 k €376 k €361 k €313,3 k €285,4 k €236,1 k €197,9 k €153,3 k €42,3 k €5,4 k €-16 k €-19,1 k €-52,2 k €
Total assets2,2 M €2,2 M €2,1 M €2,1 M €2 M €2,2 M €437,5 k €383,5 k €374,3 k €344,4 k €286,8 k €262,7 k €262,6 k €238,1 k €132,8 k €110 k €106,2 k €100,6 k €44,1 k €
Cash1,1 M €1,2 M €1,3 M €1,4 M €1,5 M €1,6 M €186,1 k €192,3 k €207,9 k €202,9 k €255,1 k €166,8 k €187,3 k €75,1 k €83 k €89,8 k €55,4 k €7,4 k €39,2 k €
Debts13,7 k €15,8 k €13,7 k €45,9 k €30,8 k €264,9 k €40,6 k €5,5 k €4 k €29,1 k €1,4 k €22,5 k €64,8 k €74 k €90,5 k €104,7 k €113,5 k €113,7 k €96,3 k €
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Dirk Verhaeghe

Mandate

Active
Greet Damme

Mandate

Active

Ended mandates

Dirk Verhaeghe

Manager · since 13 septembre 2006

Ended
Dirk Verhaeghe

Manager

Ended
Verhaeghe dirk

Mandate

Ended
At this address

Other companies at this address

CompanyCBE no.
Amalus Therapeutics● Bankrupt
0803.929.268
APCOR R&M● Active
0600.952.909
Ardoyen● Active
0875.102.821
AVROXA● Active
0687.774.936
Benebiose● Active
0784.521.548
BioNeering● Active
0807.194.309
CONTREL EUROPE● Active
0426.204.637
CRODEON TECHNOLOGIES● Active
0642.754.761
Cryptobiotix● Active
0762.565.104
Gulliver Biomed● Active
0692.527.837
ImplicitMeasures.com● Bankrupt
0657.989.701
Inbiose● Active
0534.887.593
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT● Active
0440.054.752
Inspect● Active
0645.950.417
INVIBES ADVERTISING● Active
0836.533.938
KYTOS● Active
0768.755.286
Lares Solutions● Active
1015.346.906
MAYAKU PHARMACEUTICAL DEVELOPMENT● Active
0755.350.975
Microbial Resource Management Health● Active
0742.910.132
Microbial Resource Management Technologies● Active
0667.765.816
Annual accounts

Full financial information

202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date14/07/202614/08/202511/07/202413/07/202327/08/202202/06/2021
General meeting28/05/202629/05/202530/05/202425/05/202326/05/202227/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

19 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202528/05/202614/07/2026DutchPDF
Micro model31/12/202429/05/202514/08/2025DutchPDF
Micro model31/12/202330/05/202411/07/2024DutchPDF
Micro model31/12/202225/05/202313/07/2023DutchPDF
Micro model31/12/202126/05/202227/08/2022DutchPDF
Micro model31/12/202027/05/202102/06/2021DutchPDF
Micro model31/12/201928/05/202013/08/2020DutchPDF
Micro model31/12/201830/05/201929/06/2019DutchPDF
Micro model31/12/201724/05/201825/06/2018DutchPDF
Micro model31/12/201625/05/201705/07/2017DutchPDF
Abridged model31/12/201526/05/201605/07/2016DutchPDF
Abridged model31/12/201428/05/201517/07/2015DutchPDF
Abridged model31/12/201330/05/201402/10/2014DutchPDF
Abridged model31/12/201225/04/201310/06/2013DutchPDF
Abridged model31/12/201131/05/201225/07/2012DutchPDF
Abridged model31/12/201026/05/201119/08/2011DutchPDF
Abridged model31/12/200927/05/201031/08/2010DutchPDF
Abridged model31/12/200828/05/200931/08/2009DutchPDF
Abridged model31/12/200729/05/200828/08/2008DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Dirk Verhaeghe

Mandate

Active
Greet Damme

Mandate

Active

Ended mandates

Dirk Verhaeghe

Manager · since 13 septembre 2006

Ended
Dirk Verhaeghe

Manager

Ended
Verhaeghe dirk

Mandate

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates28/03/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other20/09/2006
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202577,4 k €↓
  2. 2024
    Annual accounts 202498,6 k €↑
  3. 2023
    Annual accounts 202336,5 k €↑
  4. 2022
    Annual accounts 202217,4 k €↓
  5. 2021
    Annual accounts 2021100,7 k €↓
  6. 2020
    Annual accounts 20201,5 M €↑
  7. 2019
    Annual accounts 201920,8 k €↑
  8. 2018
    Annual accounts 201815 k €↓
  9. 2017
    Annual accounts 201747,7 k €↑
  10. 2016
    Annual accounts 201627,9 k €↓
  11. 2015
    Annual accounts 201549,4 k €↑
  12. 2014
    Annual accounts 201438,2 k €↓
  13. 2013
    Annual accounts 201344,5 k €↓
  14. 2012
    Annual accounts 2012111 k €↑
  15. 2011
    Annual accounts 201136,9 k €↑
  16. 2010
    Annual accounts 201022,3 k €↑
  17. 2009
    Annual accounts 20092,2 k €↓
  18. 2008
    Annual accounts 200833,1 k €↑
  19. 2007
    Annual accounts 2007-82,2 k €
  20. 18/09/2006
    IncorporationPrivate limited company